- Home
- RLAY vs HEPS Comparison
RLAY vs HEPS Comparison
Compare RLAY & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | HEPS |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | Turkey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 870.4M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RLAY | HEPS |
|---|---|---|
| Price | $7.69 | $2.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $16.00 | $3.07 |
| AVG Volume (30 Days) | ★ 2.1M | 225.8K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,355,000.00 | ★ $1,504,533,586.00 |
| Revenue This Year | $20.47 | $41.69 |
| Revenue Next Year | N/A | $29.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 56.77 |
| 52 Week Low | $1.78 | $2.15 |
| 52 Week High | $8.36 | $3.85 |
Technical Indicators
Market Signals| Indicator | RLAY | HEPS |
|---|---|---|
| Relative Strength Index (RSI) | 58.73 | 54.89 |
| Support Level | $7.23 | $2.29 |
| Resistance Level | $8.36 | $2.40 |
| Average True Range (ATR) | 0.51 | 0.08 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 69.18 | 90.16 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.